BioNTech SE ROE - Return on Equity 2019-2025 | BNTX

BioNTech SE return on equity for the quarter ending March 31, 2025 was -3.96.

  • BioNTech SE average return on equity for 2024 was -1.92, a 110.96% increase from 2023.
  • BioNTech SE average return on equity for 2023 was 17.52, a 78.84% decline from 2022.
  • BioNTech SE average return on equity for 2022 was 82.81, a 40.74% decline from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

BioNTech SE ROE - Return on Equity 2019-2025 | BNTX

  • BioNTech SE average return on equity for 2024 was -1.92, a 110.96% increase from 2023.
  • BioNTech SE average return on equity for 2023 was 17.52, a 78.84% decline from 2022.
  • BioNTech SE average return on equity for 2022 was 82.81, a 40.74% decline from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.